Cramer scrutinizes the stock market’s winners along with losers

In a market in which is actually markedly difficult for retailers along with enamored with all things technology, CNBC’s Jim Cramer has watched a rift form between winning along with losing stocks.

“This specific is actually a definitely Dickensian, ‘Tale-of-Two-Cities’-style market,” the “Mad Money” host said. “the item is actually at once the best of times if you own the banks along with the techs or the industrials, along with the item’s the worst of times if you own the drug stocks, the consumer packaged goods plays or anything retail. This specific dichotomy plays out every single day.”

Cramer pointed to Citi Research’s twin downgrades of Macy’s along with J.C. Penney’s stocks to “sell” by neutral ratings. Citi’s analysts cited the department store chains’ lack of strategic initiatives to differentiate themselves by competing retailers.

The overall negativity in Citi’s note made Cramer wonder if the retailers could be subject to “a fate worse than death.”

“Citi says in which J.C. Penney is actually withering, in which they’ve cut expenses to the bone — no, through the bone — [along with] they need to add the expenses back,” Cramer said. “The merchandise is actually not distinguished, the home goods have lower gross margins. There seems to be no way out.”

As for Macy’s, Citi said the retailer needs to be able to cut its 8 percent dividend yield, which is actually the main reason anyone would likely want to own the stock, Cramer said.

If the department stores are seeing the worst of times, Amazon is actually seeing the best, the “Mad Money” host contended, citing the e-commerce giant’s monster earnings beat.

“the item’s almost as if Amazon is actually a country within itself — the item’s got the best tech, the best selections, the best prices, along with the best delivery,” Cramer said. “Heck, CEO Jeff Bezos may even develop the best space program.”

however for Amazon’s “haves,” there are a fair share of “have-nots,” particularly drug companies in which have been scrambling in anticipation of the online giant entering the prescription drug space.

Cramer cited CVS, which has been racing to get ahead of Amazon’s possible move into pharmaceutical sales via merger talks with health insurer Aetna.

from the meantime, investors have all however declared war on pharma giants Merck, Celgene along with Gilead. Marketshare losses at Merck, slashed guidance at Celgene along having a sales slowdown at Gilead contributed to the major declines in their stocks.

from the meantime, internet giant Alphabet, whose Google search platform is actually at the nexus of so many online purchases, is actually seeing accelerated volume in ad clicks along with core search usage.

“What works in This specific market works very well, along with what doesn’t work often is actually left by the wayside,” Cramer said.

Another group in which’s working is actually the bank stocks, which Cramer said are so stable (with the exception of Wells Fargo) in which the item hardly matters who President Donald Trump names the brand new chairman of the Federal Reserve.

“What can I say? The bottom line is actually in which if you stroll down the wrong aisle of the stock supermarket, you could get eaten by a bear. You get from the right one, like the banks, the techs [or] the industrials, then you’re riding the bull,” the “Mad Money” host said.